Net profit of Corona Remedies declined 8.19% to Rs 41.27 crore in the quarter ended December 2025 as against Rs 44.95 crore during the previous quarter ended December 2024. Sales rose 15.03% to Rs 342.42 crore in the quarter ended December 2025 as against Rs 297.69 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 342.42 | 297.69 | 15 |
| OPM % | 24.29 | 23.32 | - |
| PBDT | 83.76 | 67.97 | 23 |
| PBT | 74.31 | 58.28 | 28 |
| NP | 41.27 | 44.95 | -8 |
Powered by Capital Market - Live News